KR890009391A - 무좀 치료제 - Google Patents

무좀 치료제 Download PDF

Info

Publication number
KR890009391A
KR890009391A KR1019880016222A KR880016222A KR890009391A KR 890009391 A KR890009391 A KR 890009391A KR 1019880016222 A KR1019880016222 A KR 1019880016222A KR 880016222 A KR880016222 A KR 880016222A KR 890009391 A KR890009391 A KR 890009391A
Authority
KR
South Korea
Prior art keywords
athlete
pharmaceutical composition
foot
treating athlete
aqueous alcohol
Prior art date
Application number
KR1019880016222A
Other languages
English (en)
Other versions
KR960009415B1 (ko
Inventor
이즈미 사이또오
가오리 이께다
시게루 기도
요시오 도이
쇼헤이 에가와
Original Assignee
요시도시 가즈오
시오노기세이야꾸가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시도시 가즈오, 시오노기세이야꾸가부시끼가이샤 filed Critical 요시도시 가즈오
Publication of KR890009391A publication Critical patent/KR890009391A/ko
Application granted granted Critical
Publication of KR960009415B1 publication Critical patent/KR960009415B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

무좀 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
종축은 피부내의 CCZ농도를 나타내고, 횡축은 시간을 나타낸다.
피부내의 CCZ 잔류량을 대조용으로 “●”기호로 나타내고, 실시예1의 조성물에는 “○"기호로 나타낸다.

Claims (4)

  1. 기본 성분으로서 크로코나졸 히드로클로라이드 약 0.1% 내지 약 2.5% 및 에틸아크릴레이트-메틸메타크릴레이트 공중합체 약1%-15%을 수성 알코올 중에 함유하는 무좀 치료용 화학 조성물.
  2. 제1항에 있어서, 기본 성분에 증검제 약0.1% 내지 약2.5%이 첨가하는 무좀 치료용 약학 조성물.
  3. 제1 또는 2항에 있어서, 상기 수성 알코올이 에탄올 또는 이소프로판올 약55% 내지 약75%인 무좀 치료용 약학 조성물.
  4. 제2항에 있어서, 상기 증검제는 에틸 셀룰로오스, 히드록시프로필 셀룰로오스 또는 히드록시프로필메틸셀룰로오스인 무좀 치료용 약학 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880016222A 1987-12-08 1988-12-06 무좀 치료제 KR960009415B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62310479A JPH0818983B2 (ja) 1987-12-08 1987-12-08 水虫治療剤
JP310479/1987 1987-12-08

Publications (2)

Publication Number Publication Date
KR890009391A true KR890009391A (ko) 1989-08-01
KR960009415B1 KR960009415B1 (ko) 1996-07-19

Family

ID=18005734

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016222A KR960009415B1 (ko) 1987-12-08 1988-12-06 무좀 치료제

Country Status (8)

Country Link
US (1) US4935241A (ko)
EP (1) EP0319965B1 (ko)
JP (1) JPH0818983B2 (ko)
KR (1) KR960009415B1 (ko)
AT (1) ATE61522T1 (ko)
DE (1) DE3862017D1 (ko)
ES (1) ES2036661T3 (ko)
GR (1) GR3001862T3 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794378B2 (ja) * 1989-08-18 1995-10-11 久光製薬株式会社 エアゾール剤
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US20030228382A1 (en) * 2002-06-06 2003-12-11 Dr. Ivar Roth Foot Fixer Kit
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
KR101333892B1 (ko) 2005-09-29 2013-11-27 노파르티스 아게 항진균 조성물
PL2191828T3 (pl) * 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US20140100285A1 (en) * 2011-05-26 2014-04-10 Novartis Ag Compositions of percutaneous administration of physiologically active agents
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619826A (en) * 1983-05-23 1986-10-28 The Dow Chemical Company Acne control method
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition

Also Published As

Publication number Publication date
ES2036661T3 (es) 1993-06-01
JPH01149725A (ja) 1989-06-12
KR960009415B1 (ko) 1996-07-19
JPH0818983B2 (ja) 1996-02-28
DE3862017D1 (de) 1991-04-18
EP0319965B1 (en) 1991-03-13
ATE61522T1 (de) 1991-03-15
GR3001862T3 (en) 1992-11-23
EP0319965A1 (en) 1989-06-14
US4935241A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
NO883555D0 (no) Innretning for applisering av implantater.
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
KR910019618A (ko) 발기부전증 치료용 제약 조성물
KR890009391A (ko) 무좀 치료제
KR950703953A (ko) 2-아미노-6-n-프로필아미노-4, 5, 6, 7-테트라하이드로벤조티아졸(프라미펙솔)의 항우울제로서의 용도(Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol)as an antidepressant drug)
KR970025615A (ko) 암 전이 억제제
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
PT788480E (pt) Cristalizacao de levobupivacaina e seus analogos
KR890009385A (ko) 피막 형성성 항진균제 조성물
KR870007118A (ko) 광학적으로 순수한 화합물 및 그의 제조 방법
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
AR017858A1 (es) Derivados de acido fenilaminoalquilcarboxilico utiles como estimulantes de los beta3-adrenoceptores, composicion farmaceutica, estimulante de losbeta3-adrenoceptores, usos en la fabricacion de medicamentos y procedimiento de fabricacion
BR0213372A (pt) Medicamento compreendendo combinação de derivado de traizaespiro[5,5]undecano com inibidor de citocromo p450 isozima 3a4 e/ou inibidor de glocoproteìna-p
KR880004810A (ko) 소화성 궤양 치료제
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR870008885A (ko) 2-알콕시-n(1-아자비사이클로 [2,2,2] 옥트-3-일) 벤즈 아미드-n-옥사이드를 사용하여 구토증을 억제하는 방법
KR900017599A (ko) 종양 치료용 약학 조성물
KR910021244A (ko) 당뇨병성 괴저 치료제
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050711

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee